Consensus Transgene

Stocks

TNG

FR0005175080

Biotechnology & Medical Research

Real-time Euronext Paris 00:29:59 29/10/2026 HKT			5-day change	1st Jan Change
0.7400 ^EUR	+8.82%		+9.14%	-22.92%

10-05	Transgene to present preclinical data on PoxSTG-EEV
09-25	Transgene provides update on its operations

Evolution of the Average Target: Transgene

Evolution of the Average Target - Transgene

Evolution of the Target Price: Transgene

Evolution of the Target Price - Transgene

Changes in Analyst Recommendations: Transgene

0def7e.JdnpwmOYG3B9x2GN3HTc4-CT-xFTRg03_uYpbm87FTQ.cp6N-w_5VhcYlQW0rhzqvLbejUQlE0RmyIN9IT55QARpjoOwDO0iJUi0NA~ee727608ab0248eeca689befce5b943b

Analysts' recommendations: Transgene

06-25	Oddo BHF Stays Positive on Transgene
04-07	Transgene stands out following licensing agreement with NEC Bio
11-27	Oddo BHF Lowers Target Price on Transgene but Remains Upbeat
13/10/25	Transgene and BioInvent International AB Jointly Present a Poster on Transational Data and Updated Clinical Results from the Phase I Study of BT-001	CI
19/09/25	Transgene: analysts reiterate their recommendations after results
17/09/25	The day the Fed resumed its rate cuts
06/11/24	Transgene: Invest Securities remains Buy
15/10/24	Transgene: Invest Securities confirms its Buy recommendation
26/09/24	Transgene: Invest Securities confirms its opinion
06/06/23	Transgene: Invest Securities confirms its Buy rating
05/06/23	Transgene: Invest Securities reiterates its recommendation
22/03/23	Transgene: Invest Securities reduces its target
10/01/23	Transgene: Invest Securities confirms its Buy rating

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TRANSGENE			-	-	+61.76%
	WUXI APPTEC CO., LTD.					+41.32%
	ARGENX SE					+28.63%
	LONZA GROUP AG					+9.56%
	IQVIA HOLDINGS INC.					+12.15%
	BEONE MEDICINES AG					+19.23%
	REVOLUTION MEDICINES, INC.					+39%
	CELLTRION, INC.					+42.31%
	GENMAB A/S					+6.5%
	WUXI BIOLOGICS (CAYMAN) INC.					+35.02%
	Average					+29.55%
	Weighted average by Cap.					+26.21%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.6800EUR

Average target price

1.100EUR

Spread / Average Target

+61.76%

High Price Target

1.100EUR

Spread / Highest target

+61.76%

Low Price Target

1.100EUR

Spread / Lowest Target

+61.76%

Analyst Consensus Detail

Analyst consensus - Transgene

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Transgene

Stock Market
Stocks
TNG Stock
Consensus Transgene

The best tools reserved for subscribers to boost the performance of your investments!